Rare diseases
Investigational molecules
Locations
Back to Bulgaria55 clinical trials in Vratsa, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
BulgariaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
BulgariaStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
BulgariaEfficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms
BulgariaVMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
BulgariaA study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia
BulgariaA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
BulgariaLong-Term Safety Study of Direclidine in Adults with Schizophrenia
BulgariaA study testing direclidine compared to placebo in adults with schizophrenia who need hospital care
BulgariaStudy of MT-501 in patients with active Crohn's Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder
BulgariaStudy of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on asthma and COPD treatments, evaluating novel therapies and combinations to improve lung function and reduce exacerbations.
Multiple trials testing innovative inhaler formulations and biological treatments for better disease control.
Groundbreaking studies in breast cancer and leukemia, with particular focus on targeted therapies and combination treatments.
Innovative approaches combining established treatments with novel therapeutic agents.
Comprehensive research in psychiatric disorders, including trials for schizophrenia, anxiety, and depression treatments.
Focus on developing effective adjunctive therapies and new treatment options for resistant cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
